(Q48494063)

12 February 2018

title

Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole (English)

1 reference

12 February 2018

author name string

T M Tzschentke

series ordinal

1

1 reference

12 February 2018

W J Schmidt

series ordinal

2

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

12 February 2018

published in

Neuroscience Letters

1 reference

12 February 2018

volume

242

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

114-116

1 reference

12 February 2018

Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

Excitatory amino acid receptors and synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

The pharmacology and mechanism of action of riluzole

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

NMDA antagonists make learning and recall state-dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

Clinical experience with excitatory amino acid antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

The effects of MK801 on place conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900023-8

7 January 2021

10.1016/S0304-3940(98)00023-8

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018